Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome.

Woo TE, Lim R, Heirali AA, Acosta N, Rabin HR, Mody CH, Somayaji R, Surette MG, Sibley CD, Storey DG, Parkins MD.

Sci Rep. 2019 May 3;9(1):6871. doi: 10.1038/s41598-019-42862-y.

2.

The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome.

Heirali AA, Acosta N, Storey DG, Workentine ML, Somayaji R, Laforest-Lapointe I, Leung W, Quon BS, Berthiaume Y, Rabin HR, Waddell BJ, Rossi L, Surette MG, Parkins MD.

J Cyst Fibros. 2019 Mar 8. pii: S1569-1993(19)30028-1. doi: 10.1016/j.jcf.2019.02.010. [Epub ahead of print]

PMID:
30857926
3.

Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis.

Woo TE, Lim R, Surette MG, Waddell B, Bowron JC, Somayaji R, Duong J, Mody CH, Rabin HR, Storey DG, Parkins MD.

ERJ Open Res. 2018 Jun 18;4(2). pii: 00162-2017. doi: 10.1183/23120541.00162-2017. eCollection 2018 Apr.

4.

Mixed species biofilms of Fusobacterium necrophorum and Porphyromonas levii impair the oxidative response of bovine neutrophils in vitro.

Lockhart JS, Buret AG, Ceri H, Storey DG, Anderson SJ, Morck DW.

Anaerobe. 2017 Oct;47:157-164. doi: 10.1016/j.anaerobe.2017.05.008. Epub 2017 May 17.

PMID:
28526497
5.

The effects of inhaled aztreonam on the cystic fibrosis lung microbiome.

Heirali AA, Workentine ML, Acosta N, Poonja A, Storey DG, Somayaji R, Rabin HR, Whelan FJ, Surette MG, Parkins MD.

Microbiome. 2017 May 5;5(1):51. doi: 10.1186/s40168-017-0265-7.

6.

Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study.

Edwards BD, Greysson-Wong J, Somayaji R, Waddell B, Whelan FJ, Storey DG, Rabin HR, Surette MG, Parkins MD.

J Clin Microbiol. 2017 Jul;55(7):2074-2085. doi: 10.1128/JCM.02556-16. Epub 2017 Apr 26.

7.

Effect of freezing sputum on Pseudomonas aeruginosa population heterogeneity.

Poonja A, Heirali A, Workentine M, Storey DG, Somayaji R, Rabin HR, Surette MG, Parkins MD.

J Cyst Fibros. 2017 May;16(3):353-357. doi: 10.1016/j.jcf.2017.01.004. Epub 2017 Jan 24.

8.

Digestomics: an emerging strategy for comprehensive analysis of protein catabolism.

Bingeman TS, Perlman DH, Storey DG, Lewis IA.

Curr Opin Biotechnol. 2017 Feb;43:134-140. doi: 10.1016/j.copbio.2016.11.004. Epub 2016 Dec 23. Review.

PMID:
28025112
9.

Virulence adaptations of Pseudomonas aeruginosa isolated from patients with non-cystic fibrosis bronchiectasis.

Woo TE, Duong J, Jervis NM, Rabin HR, Parkins MD, Storey DG.

Microbiology. 2016 Dec;162(12):2126-2135. doi: 10.1099/mic.0.000393.

10.

Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.

Heirali A, McKeon S, Purighalla S, Storey DG, Rossi L, Costilhes G, Drews SJ, Rabin HR, Surette MG, Parkins MD.

PLoS One. 2016 Feb 9;11(2):e0148534. doi: 10.1371/journal.pone.0148534. eCollection 2016.

11.

Development and Validation of a PCR Assay To Detect the Prairie Epidemic Strain of Pseudomonas aeruginosa from Patients with Cystic Fibrosis.

Workentine M, Poonja A, Waddell B, Duong J, Storey DG, Gregson D, Somayaji R, Rabin HR, Surette MG, Parkins MD.

J Clin Microbiol. 2016 Feb;54(2):489-91. doi: 10.1128/JCM.02603-15. Epub 2015 Dec 9.

12.

Phenotypic and Genotypic Comparison of Epidemic and Non-Epidemic Strains of Pseudomonas aeruginosa from Individuals with Cystic Fibrosis.

Duong J, Booth SC, McCartney NK, Rabin HR, Parkins MD, Storey DG.

PLoS One. 2015 Nov 23;10(11):e0143466. doi: 10.1371/journal.pone.0143466. eCollection 2015.

13.

Potential of metabolomics to reveal Burkholderia cepacia complex pathogenesis and antibiotic resistance.

Shommu NS, Vogel HJ, Storey DG.

Front Microbiol. 2015 Jul 13;6:668. doi: 10.3389/fmicb.2015.00668. eCollection 2015. Review.

14.

Hydroxy-tryptophan containing derivatives of tritrpticin: modification of antimicrobial activity and membrane interactions.

Arias M, Jensen KV, Nguyen LT, Storey DG, Vogel HJ.

Biochim Biophys Acta. 2015 Jan;1848(1 Pt B):277-88. doi: 10.1016/j.bbamem.2014.08.024. Epub 2014 Aug 29.

15.

Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain.

Parkins MD, Glezerson BA, Sibley CD, Sibley KA, Duong J, Purighalla S, Mody CH, Workentine ML, Storey DG, Surette MG, Rabin HR.

J Clin Microbiol. 2014 Apr;52(4):1127-35. doi: 10.1128/JCM.03218-13. Epub 2014 Jan 22.

16.

Mechanism of action of puroindoline derived tryptophan-rich antimicrobial peptides.

Haney EF, Petersen AP, Lau CK, Jing W, Storey DG, Vogel HJ.

Biochim Biophys Acta. 2013 Aug;1828(8):1802-13. doi: 10.1016/j.bbamem.2013.03.023. Epub 2013 Apr 2.

17.

Lethality and cooperation of Pseudomonas aeruginosa quorum-sensing mutants in Drosophila melanogaster infection models.

Lutter EI, Purighalla S, Duong J, Storey DG.

Microbiology. 2012 Aug;158(Pt 8):2125-32. doi: 10.1099/mic.0.054999-0. Epub 2012 May 24.

PMID:
22628480
18.

The stringent response is essential for Pseudomonas aeruginosa virulence in the rat lung agar bead and Drosophila melanogaster feeding models of infection.

Vogt SL, Green C, Stevens KM, Day B, Erickson DL, Woods DE, Storey DG.

Infect Immun. 2011 Oct;79(10):4094-104. doi: 10.1128/IAI.00193-11. Epub 2011 Jul 25.

19.

Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections.

Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, Rabin HR, Surette MG.

PLoS Pathog. 2008 Oct;4(10):e1000184. doi: 10.1371/journal.ppat.1000184. Epub 2008 Oct 24.

20.

Pseudomonas aeruginosa cystic fibrosis isolates from individual patients demonstrate a range of levels of lethality in two Drosophila melanogaster infection models.

Lutter EI, Faria MM, Rabin HR, Storey DG.

Infect Immun. 2008 May;76(5):1877-88. doi: 10.1128/IAI.01165-07. Epub 2008 Feb 19.

21.

The GacS sensor kinase controls phenotypic reversion of small colony variants isolated from biofilms of Pseudomonas aeruginosa PA14.

Davies JA, Harrison JJ, Marques LL, Foglia GR, Stremick CA, Storey DG, Turner RJ, Olson ME, Ceri H.

FEMS Microbiol Ecol. 2007 Jan;59(1):32-46.

22.

Quorum-sensing mutations affect attachment and stability of Burkholderia cenocepacia biofilms.

Tomlin KL, Malott RJ, Ramage G, Storey DG, Sokol PA, Ceri H.

Appl Environ Microbiol. 2005 Sep;71(9):5208-18.

23.

Pseudomonas aeruginosa relA contributes to virulence in Drosophila melanogaster.

Erickson DL, Lines JL, Pesci EC, Venturi V, Storey DG.

Infect Immun. 2004 Oct;72(10):5638-45.

24.

Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa.

Tunney MM, Ramage G, Field TR, Moriarty TF, Storey DG.

Antimicrob Agents Chemother. 2004 May;48(5):1879-81.

25.
26.

Pseudomonas aeruginosa quorum-sensing systems may control virulence factor expression in the lungs of patients with cystic fibrosis.

Erickson DL, Endersby R, Kirkham A, Stuber K, Vollman DD, Rabin HR, Mitchell I, Storey DG.

Infect Immun. 2002 Apr;70(4):1783-90.

27.
28.

Subtractive hybridization-based identification of genes uniquely expressed or hyperexpressed during biofilm growth.

Parkins MD, Altebaeumer M, Ceri H, Storey DG.

Methods Enzymol. 2001;336:76-84. No abstract available.

PMID:
11398421
29.

Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms.

De Kievit TR, Parkins MD, Gillis RJ, Srikumar R, Ceri H, Poole K, Iglewski BH, Storey DG.

Antimicrob Agents Chemother. 2001 Jun;45(6):1761-70.

30.
31.

Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity.

Gallant CV, Raivio TL, Olson JC, Woods DE, Storey DG.

Microbiology. 2000 Aug;146 ( Pt 8):1891-9.

PMID:
10931893
32.
33.

Pseudomonas aeruginosa exoenzyme S stimulates murine lymphocyte proliferation in vitro.

Barclay NG, Spurrell JC, Bruno TF, Storey DG, Woods DE, Mody CH.

Infect Immun. 1999 Sep;67(9):4613-9.

35.
37.

Linker insertion scanning of regA, an activator of exotoxin A production in Pseudomonas aeruginosa.

Raivio TL, Hoffer D, Prince RW, Vasil ML, Storey DG.

Mol Microbiol. 1996 Oct;22(2):239-54.

PMID:
8930909
38.
39.
40.

Regulation of expression of Pseudomonas exotoxin A by iron.

Frank DW, Storey DG.

Methods Enzymol. 1994;235:502-17. Review. No abstract available.

PMID:
8057922
42.

Zinc and iron regulate translation of the gene encoding Pseudomonas aeruginosa elastase.

Brumlik MJ, Storey DG.

Mol Microbiol. 1992 Feb;6(3):337-44.

PMID:
1552848
43.
44.

Effect of regB on expression from the P1 and P2 promoters of the Pseudomonas aeruginosa regAB operon.

Storey DG, Raivio TL, Frank DW, Wick MJ, Kaye S, Iglewski BH.

J Bacteriol. 1991 Oct;173(19):6088-94.

45.

In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangement.

Woods DE, Sokol PA, Bryan LE, Storey DG, Mattingly SJ, Vogel HJ, Ceri H.

J Infect Dis. 1991 Jan;163(1):143-9.

PMID:
1824596
46.

Multiple promoters control the regulation of the Pseudomonas aeruginosa regA gene.

Storey DG, Frank DW, Farinha MA, Kropinski AM, Iglewski BH.

Mol Microbiol. 1990 Mar;4(3):499-503.

PMID:
2113156
47.

Identification of regB, a gene required for optimal exotoxin A yields in Pseudomonas aeruginosa.

Wick MJ, Frank DW, Storey DG, Iglewski BH.

Mol Microbiol. 1990 Mar;4(3):489-97.

PMID:
2113155
48.

Structure, function, and regulation of Pseudomonas aeruginosa exotoxin A.

Wick MJ, Frank DW, Storey DG, Iglewski BH.

Annu Rev Microbiol. 1990;44:335-63. Review. No abstract available.

PMID:
2123620
49.

Differential regulation by iron of regA and toxA transcript accumulation in Pseudomonas aeruginosa.

Frank DW, Storey DG, Hindahl MS, Iglewski BH.

J Bacteriol. 1989 Oct;171(10):5304-13.

50.

Nucleotide sequence of the coding and flanking regions of the human parainfluenza virus type 3 fusion glycoprotein gene.

Côté MJ, Storey DG, Kang CY, Dimock K.

J Gen Virol. 1987 Apr;68 ( Pt 4):1003-10. Erratum in: J Gen Virol 1987 Aug;68(Pt 8):2271.

PMID:
3033123

Supplemental Content

Loading ...
Support Center